510(k) K123271
K123271 is an FDA 510(k) premarket notification submitted by Microgenics Corp. for the device "ABBOTT PHENOBARBITAL ASSAY". The FDA issued a decision of Substantially Equivalent on Apr 26, 2013. The device falls under product code DLZ (Enzyme Immunoassay, Phenobarbital), a Class II device regulated under 21 CFR 862.3660. Microgenics Corp. has 106 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Apr 26, 2013
- Date Received
- Oct 19, 2012
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Enzyme Immunoassay, Phenobarbital
- Device Class
- Class II
- Regulation Number
- 862.3660
- Review Panel
- TX
- Submission Type
- 510(k)
Need the full FDA record for Microgenics Corp.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.